NCT06035757View on ClinicalTrials.gov

The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

August 15, 2025

Study Completion Date

August 15, 2025

Conditions
Emergence DeliriumStrabismusPediatric ALL
Interventions
DRUG

Bridion 200 MG in 2 ML Injection

Sugammadex is administered at the end of surgery after assessment of the level of neuromuscular blockade is done. The dosage of each reversal agent is determined with response to TOF or PTC.

DRUG

Pyridostigmine Bromide 5 MG/ML

Pyridostigmine is administered at the end of surgery after assessment of the level of neuromuscular blockade is done. The dosage of each reversal agent is determined with response to TOF.

Trial Locations (1)

05030

RECRUITING

Konkuk University Medical Center, Seoul

All Listed Sponsors
lead

Konkuk University Medical Center

OTHER